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Abstract
Background Vortex keratopathy, arising as a side effect of
several medications, is characterized by golden-brown
deposits in the cornea.
Methods A 41-year-old woman treated for sarcoidosis with
hydroxychloroquine therapy and suffering from vortex
keratopathy was examined by in vivo confocal microscopy.
Scans of both corneas were performed.
Results By slit lamp examination, the left but not the right
eye showed a golden-brown deposit throughout the cornea.
In vivo confocal microscopy revealed the presence of
highly reflective, dot-like intracellular inclusions concen-
trated in the basal epithelial layer. They were also detected
within the anterior and posterior stroma, but not within the
endothelium. In regions of the anterior stroma, devoid of
inclusions, hyperreflective ramified keratocytes were ob-
served, forming an extended interconnecting network.
Conclusion In addition to the granular deposits, in vivo
confocal microscopy revealed hyperreflective, possibly
phagocytic keratocytes.
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Introduction
Vortex keratopathy (cornea verticillata) is characterized by
a whorl-like pattern of greyish or golden-brown deposits in
the corneal epithelium. It occurs in Fabry’s disease and as a
side effect of various systemic medications, namely
amiodarone, aminoquinolones, indometacin, suramin, and
tamoxin [6]. These drugs share cationic amphiphilic
properties, allowing them to accumulate within lysosomes
[3]. They give rise to undegradable inclusion bodies [9].
The whorl-like pattern may result from the centripetal
migration of deposit-laden limbal epithelial cells [4].
Corneal deposits seldom affect visual acuity, and typically
resolve once the medication is stopped [7].
By in vivo confocal microscopy, chloroquine [10] and
amiodarone deposits in the cornea have recently been
described to occur in the basal epithelial layer, stroma, and
in the case of amiodarone, also in the endothelium [2].
Using the same technique, we describe corneal deposits in a
patient with hydroxychloroquine keratopathy.
Case report
A 41-year-old woman with a 1-year history of sarcoidosis
was referred to our clinic by her general physician for
ophthalmologic control before introduction of hydroxy-
chloroquine treatment (2×200 mg/day). Best-corrected
visual acuity was 20/20 in both eyes. Intraocular pressure
was normal and, by slit-lamp examination and fundu-
scopy, neither the anterior segment nor the fundus showed
visible pathologic traits. Visual field, multifocal ERG, and
EOG were normal. Six months later, the patient returned
to the clinic complaining of foreign body sensation,
dryness and burning in both eyes. Best-corrected visual
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acuity (20/20 in both eyes) was not affected. Slit-lamp
examination revealed golden-brown deposits in the left
cornea that were more pronounced near the limbus
(Fig. 1). No deposits were visible in the right eye.
Funduscopy was normal in both eyes. Diagnosis of dry
eye was confirmed by a Schirmer test. Visual field,
multifocal ERG, and EOG were repeated and showed no
abnormalities.
In vivo confocal microscopy was performed using a
Heidelberg Retina Tomograph II, Rostock Cornea
Module (Heidelberg Engineering GmbH, Dossenheim,
Germany). After topical anesthesia (0.4% oxybupro-
caine, Novartis Pharma, Bern, Switzerland), Lacryvisc
Gel (Alcon Labs, Zug, Switzerland) was applied before
aligning the lens. Raw full-screen images were captured
throughout the cornea and are presented without further
image treatment.
Observations
In the cornea of the left eye, highly reflective intracellular
inclusions, measuring between 2 and 15 μm in diameter,
were observed in the basal epithelial cell layer (Fig. 2a).
They were also detected throughout the anterior stroma
(Fig. 2b,c), but decreased in number in the mid-stroma
(Fig. 2d). No reflective inclusion bodies were observed in
the endothelial cell layer. In the anterior stroma, however,
highly reflective ramified cells were revealed (Fig. 2b,c). In
several instances, these cells were interconnected and
Fig. 1 Golden-brown deposits in the temporal limbus after hydroxy-
chloroquine medication. Slit-lamp examination
Fig. 2 In vivo confocal microscopy of the left cornea. Optical sections
of basal epithelial layer (a), anterior (b, c), and mid-stroma (d). a
Diffuse bright intracellular inclusion bodies in the basal epithelial
layer, as recognized by its reticular structure. b Granular deposits
(upper right) and highly reflective keratocytes (lower left) within the
anterior stroma. c Anterior stroma with reflective keratocytes. Note
absence of granular deposits in the focal plane of reflective
keratocytes interconnected into a network. d Midstroma with few
reflective dot-like deposits. Bar, 50 μm
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formed an extended network, suggesting that they represent
keratocytes. Their high reflectiveness, and the fact that no
inclusion bodies were found in their surroundings, suggest
that they had phagocytosed the deposits.
In the right eye, a few bright microdots were present
exclusively in the basal epithelial cell layer (not shown).
Discussion
Medication with members of the chloroquine family
(chloroquine, hydroxychlorique, amodiaquine) may pro-
duce ocular toxicity involving the cornea (vortex kerato-
pathy), ciliary body, lens (posterior subcapsular cataracts),
and retina (bull’s eye maculopathy) [5]. Chloroquine is
rapidly absorbed and becomes highly concentrated in
several tissues throughout the body. Corneal deposits
(verticillata) can be demonstrated in most patients taking
chloroquine, but these changes very rarely impair vision.
Such deposits form more frequently with chloroquine than
hydroxychloroquine and often develop within 2–3 weeks
following initiation [5]. They are located in the epithelium
and anterior stroma and, in most cases, are reversible.
The present report demonstrates by in vivo confocal
microscopy that the golden-brown deposit detected by slit
lamp examination in the hydroxychloroquine-laden cornea
corresponds to granular inclusions in the epithelium and
stroma. A similar distribution was noted in chloroquine-
induced keratopathy [10], whereas in advanced amiodar-
one-induced keratopathy, deposits were also found in the
endothelium [2]. Nevertheless, the hydroxychloroquine
inclusions strongly resemble those induced by chloroquine
[10] and amiodarone [2], and may correspond to intracel-
lular lysosome-like corpuscles containing phospholipid
complexes [3, 9].
Most importantly, in vivo confocal microscopy revealed,
in the anterior stroma, the presence of highly reflective
ramified keratocytes with extended cytoplasmic processes
forming an interconnecting network. Such hyperreflection
is not detected in the normal cornea where, at best, the
nucleus and perinuclear cytoplasm can be perceived.
Interconnecting cellular processes were revealed, however,
by vital staining of isolated cornea [8]. Remarkably, in the
present case, no granular inclusions could be detected in the
surroundings of reflective keratocytes, evoking the possi-
bility that these keratocytes were actively phagocytizing
and accumulating inclusion bodies. It has been shown that,
upon corneal injury and infection, activated keratocytes
indeed exert macrophage function [1].
Chloroquine-induced deposits are located intracellularly
within lysosomes [9]. Intracellular accumulation of unde-
gradable material might ultimately lead to cell death, the
debris being phagocytized by neighboring keratocytes. Cell
death, in turn, might account for the observed decrease in
keratocyte density in amiodarone keratopathy [2], while
phagocytosis might account for the disappearance of
deposits when medication has stopped.
Conclusively, in vivo confocal microscopy revealed,
upon hydroxychloroquine medication, the formation of
corneal inclusion bodies that, in the anterior stroma, are
likely to be phagocytosed by activated keratocytes, render-
ing these cells highly reflective.
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